Supplementary Fig. S3 shows analysis of lung tumor burden and tumor cell proliferation/ death in the Kras; p53 model with Keap1/ Nrf2 mutation.
No takes yet. Share an insight, caveat, or question.
DeBlasi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: